An early-stage company established at Oregon State University has a new, high-flying owner.
Agilent Technologies Inc. (NYSE: A) confirmed Thursday it acquired E-MSion, which Agilent described in a release as the "company behind the innovative electron capture dissociation technology known as the ExD cell."
Essentially, the technology looks to help researchers quickly create biotherapeutic products that treat diseases. E-MSion, which launched in 2015, said its work "unlocks new avenues of protein characterization that will be of value to drug manufacturers and researchers alike."
The Corvallis-based operation collected nearly $1 million in National Institutes of Health funding in 2021. It was one of five companies featured in a 2015 OSU new company rollout.
The two companies have worked together since 2019, Agilent leaders said in a release.
Santa Clara, Calif.-based Agilent reported close to $7 billion in fiscal year 2022 revenue. The company hovers around the very outer Fortune 500 edge.
